VITA 34 (Germany) Today
| V3V Stock | 4.24 0.02 0.47% |
Performance0 of 100
| Odds Of DistressOver 52
|
VITA 34 is selling for under 4.24 as of the 29th of November 2024; that is 0.47 percent increase since the beginning of the trading day. The stock's last reported lowest price was 4.24. VITA 34 has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for VITA 34 AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of May 2023 and ending today, the 29th of November 2024. Click here to learn more.
Moving together with VITA Stock
Moving against VITA Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
VITA Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VITA 34's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VITA 34 or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Jakub Baran |
| Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
VITA 34 AG (V3V) is traded on XETRA Stock Exchange in Germany and employs 775 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 97.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VITA 34's market, we take the total number of its shares issued and multiply it by VITA 34's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. VITA 34 AG operates under Healthcare sector and is part of Medical Care Facilities industry. The entity has 15.83 M outstanding shares.
VITA 34 AG has accumulated about 33.3 M in cash with 2.73 M of positive cash flow from operations.
Check VITA 34 Probability Of Bankruptcy
Ownership AllocationVITA 34 AG shows a total of 15.83 Million outstanding shares. VITA 34 AG has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.61 % of VITA 34 outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check VITA Ownership Details
VITA 34 AG Risk Profiles
Although VITA 34's alpha and beta are two of the key measurements used to evaluate VITA 34's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.32 | |||
| Standard Deviation | 1.81 | |||
| Variance | 3.29 | |||
| Risk Adjusted Performance | (0.02) |
VITA Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in VITA 34 without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
VITA 34 Corporate Executives
Elected by the shareholders, the VITA 34's board of directors comprises two types of representatives: VITA 34 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VITA. The board's role is to monitor VITA 34's management team and ensure that shareholders' interests are well served. VITA 34's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VITA 34's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk Plaga | CFO Board | Profile |
Additional Tools for VITA Stock Analysis
When running VITA 34's price analysis, check to measure VITA 34's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VITA 34 is operating at the current time. Most of VITA 34's value examination focuses on studying past and present price action to predict the probability of VITA 34's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VITA 34's price. Additionally, you may evaluate how the addition of VITA 34 to your portfolios can decrease your overall portfolio volatility.